Turning Point Benefit Group’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
BIP
NAMI
Turning Point Benefit Group's ABEV Position: Q1 2026 in Review
Turning Point Benefit Group sold out of Ambev (ABEV) in Q1 2026, closing a stake of 115 shares — an estimated $284 sold.
Turning Point Benefit Group first reported a position in ABEV in Q3 2025 and held it in 2 quarters. The position peaked at $284 in Q4 2025. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.
- Turning Point Benefit Group reported no remaining Ambev position as of Q1 2026 after selling out during the quarter.
- Turning Point Benefit Group sold 115 Ambev shares in Q1 2026, an estimated $284.
- Turning Point Benefit Group first reported a position in Ambev in Q3 2025 and held it in 2 quarters.
- Turning Point Benefit Group's Ambev position peaked at $284 in Q4 2025.
- 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.
Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.